A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multi-omic study reveals BTG2
as a reliable prognostic marker for early-stage non-small cell lung cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume 12, Issue 6, Pages 913-924
Publisher
Wiley
Online
2018-04-16
DOI
10.1002/1878-0261.12204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma
- (2017) Sipeng Shen et al. Clinical Epigenetics
- Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
- (2017) Bailiang Li et al. JAMA Oncology
- ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers
- (2016) Yi-Wei Wang et al. Journal of Thoracic Oncology
- Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
- (2016) Christoph Bock et al. NATURE BIOTECHNOLOGY
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation
- (2016) Benjamin Stupfler et al. Nature Communications
- Prognostic and Predictive Value inKRASin Non–Small-Cell Lung Cancer
- (2016) Kevin Wood et al. JAMA Oncology
- miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression
- (2015) Zhiwei He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
- (2015) Katarzyna B. Leszczynska et al. JOURNAL OF CLINICAL INVESTIGATION
- An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers
- (2015) Ana I. Robles et al. Journal of Thoracic Oncology
- Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
- (2015) Maria Moksnes Bjaanaes et al. Molecular Oncology
- Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
- (2014) Xiaojing Yang et al. CANCER CELL
- Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
- (2014) A. Karlsson et al. CLINICAL CANCER RESEARCH
- Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach
- (2014) Le Kang et al. STATISTICS IN MEDICINE
- Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients
- (2013) N Wagener et al. BRITISH JOURNAL OF CANCER
- Regulation of Btg2/TIS21/PC3 expression via reactive oxygen species–protein kinase C–ΝFκΒ pathway under stress conditions
- (2013) Muhammad Imran et al. CELLULAR SIGNALLING
- TIS21/BTG2/PC3 inhibits interleukin-6 expression via downregulation of STAT3 pathway
- (2013) Linh Nguyen Quy et al. CELLULAR SIGNALLING
- MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
- (2013) Adam E. Frampton et al. GASTROENTEROLOGY
- A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
- (2013) Juan Sandoval et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients
- (2013) Sandy D. Der et al. Journal of Thoracic Oncology
- BTG2 Overexpression Increases the Radiosensitivity of Breast Cancer Cells In Vitro and In Vivo
- (2013) Xudong Hu et al. ONCOLOGY RESEARCH
- Expression and significance of miRNA-21 and BTG2 in lung cancer
- (2013) Qing Sun et al. TUMOR BIOLOGY
- BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
- (2013) Yan-jun Zhang et al. TUMOR BIOLOGY
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition
- (2012) V Coppola et al. ONCOGENE
- Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells
- (2012) Sen Wei et al. TUMOR BIOLOGY
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
- (2011) F Takahashi et al. ONCOGENE
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
- (2009) M. Raponi et al. CANCER RESEARCH
- Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma
- (2009) Min Liu et al. CELL RESEARCH
- Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
- (2009) Madeleine P Ball et al. NATURE BIOTECHNOLOGY
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started